CCNB1 and AURKA are critical genes for prostate cancer progression and castration-resistant prostate cancer resistant to vinblastine
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CCNB1 and AURKA are critical genes for prostate cancer progression and castration-resistant prostate cancer resistant to vinblastine
Authors
Keywords
-
Journal
Frontiers in Endocrinology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-12-20
DOI
10.3389/fendo.2022.1106175
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Targeting AURKA in Cancer: molecular mechanisms and opportunities for Cancer therapy
- (2021) Ruijuan Du et al. Molecular Cancer
- Integrated pan‐cancer of AURKA expression and drug sensitivity analysis reveals increased expression of AURKA is responsible for drug resistance
- (2021) Noushin Miralaei et al. Cancer Medicine
- Application of Prostate Cancer Models for Preclinical Study: Advantages and Limitations of Cell Lines, Patient-Derived Xenografts, and Three-Dimensional Culture of Patient-Derived Cells
- (2019) Takeshi Namekawa et al. Cells
- Role of chemotherapy in prostate cancer
- (2018) JeannyB Aragon-Ching et al. ASIAN JOURNAL OF ANDROLOGY
- Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic Cancers
- (2018) Gladell P. Paner et al. EUROPEAN UROLOGY
- Open-label, multicenter, phase 1 study of alisertib (MLN8237), an aurora A kinase inhibitor, with docetaxel in patients with solid tumors
- (2016) Julie N. Graff et al. CANCER
- Immune Infiltration and Prostate Cancer
- (2015) Amy Strasner et al. Frontiers in Oncology
- Concurrent AURKA and MYCN Gene Amplifications Are Harbingers of Lethal TreatmentRelated Neuroendocrine Prostate Cancer
- (2015) Juan Miguel Mosquera et al. NEOPLASIA
- Androgen receptor signaling in prostate cancer
- (2014) Zoran Culig et al. CANCER AND METASTASIS REVIEWS
- EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer
- (2013) Axel Heidenreich et al. EUROPEAN UROLOGY
- Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets
- (2011) H. Beltran et al. Cancer Discovery
- Current second-line treatment options for patients with castration resistant prostate cancer (CRPC) resistant to docetaxel
- (2010) Christian Arsov et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Stabilization of N-Myc Is a Critical Function of Aurora A in Human Neuroblastoma
- (2009) Tobias Otto et al. CANCER CELL
- Efficacy of androgen deprivation therapy (ADT) in patients with advanced prostate cancer
- (2008) Robert W. Ross et al. CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More